missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human VLK Synthetic Peptide
Click to view available options
Kvantitet:
50 μg
Tamaño de la unidad:
50µg
Descripción
VLK Synthetic Peptide, PEP-0989, from Invitrogen.
VLK was identified as a novel protein kinase that was induced after the differentiation of cultured embryonic stem cells into mesendoderm. It has no homologs in invertebrates, but is highly conserved in vertebrate species although it does not belong to any known protein kinase groups. VLK is initially expressed in E-cadherin-positive anterior visceral endoderm and mesendoderm, but its expression is later confined to E-cadherin-negative mesenchyme. It is enriched in the Golgi apparatus and is thought to regulate the rate of protein export from the Golgi. Targeted disruption of VLK in mice leads to a defect in lung development and neonatal lethality. It has been suggested that mutations in VLK may be associated with the allergic condition atopy.
Especificaciones
Especificaciones
| Gen-ID (Entrez) | 91461 |
| Art | Human |
| Reningsmetod | purified |
| Tillträdesnummer | Q504Y2 |
| Vanligt namn | Human VLK |
| Koncentration | 200 μg/mL |
| Innehåll och lagring | -20°C |
| Beskrivning | Synthetic Peptide |
| Formatera | Liquid |
| Formulering | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Mostrar más |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido